High drug prices are not justified by industry’s spending on research and development

Angelis, Aris ORCID: 0000-0002-0261-4634, Polyakov, Roman, Wouters, Olivier J. ORCID: 0000-0002-2514-476X, Torreele, Els and McKee, Martin (2023) High drug prices are not justified by industry’s spending on research and development. BMJ, 380 (8371). ISSN 1756-1833

Text (High drug prices are not justified by industry’s spending on research and development) - Accepted Version Download (586kB)

• Author
• Author
• Scopus publication

Abstract

Aris Angelis and colleagues argue that by refocusing their spending drug companies could provide more innovative drugs at affordable prices

Item Type:	Article
Official URL:	https://www.bmj.com/
Additional Information:	© 2023 BMJ.
Divisions:	Health Policy
Subjects:	R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine R Medicine > RM Therapeutics. Pharmacology
Date Deposited:	09 Jan 2023 14:18
Last Modified:	25 Apr 2024 21:54
URI:	http://eprints.lse.ac.uk/id/eprint/117809

Actions (login required)

View Item